Correlation Between Generic Engineering and Krebs Biochemicals

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Generic Engineering and Krebs Biochemicals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Generic Engineering and Krebs Biochemicals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Generic Engineering Construction and Krebs Biochemicals and, you can compare the effects of market volatilities on Generic Engineering and Krebs Biochemicals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Generic Engineering with a short position of Krebs Biochemicals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Generic Engineering and Krebs Biochemicals.

Diversification Opportunities for Generic Engineering and Krebs Biochemicals

0.26
  Correlation Coefficient

Modest diversification

The 3 months correlation between Generic and Krebs is 0.26. Overlapping area represents the amount of risk that can be diversified away by holding Generic Engineering Constructi and Krebs Biochemicals and in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Krebs Biochemicals and and Generic Engineering is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Generic Engineering Construction are associated (or correlated) with Krebs Biochemicals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Krebs Biochemicals and has no effect on the direction of Generic Engineering i.e., Generic Engineering and Krebs Biochemicals go up and down completely randomly.

Pair Corralation between Generic Engineering and Krebs Biochemicals

Assuming the 90 days trading horizon Generic Engineering is expected to generate 3.91 times less return on investment than Krebs Biochemicals. But when comparing it to its historical volatility, Generic Engineering Construction is 2.01 times less risky than Krebs Biochemicals. It trades about 0.16 of its potential returns per unit of risk. Krebs Biochemicals and is currently generating about 0.31 of returns per unit of risk over similar time horizon. If you would invest  8,095  in Krebs Biochemicals and on August 28, 2024 and sell it today you would earn a total of  3,639  from holding Krebs Biochemicals and or generate 44.95% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthVery Weak
Accuracy100.0%
ValuesDaily Returns

Generic Engineering Constructi  vs.  Krebs Biochemicals and

 Performance 
       Timeline  
Generic Engineering 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Generic Engineering Construction has generated negative risk-adjusted returns adding no value to investors with long positions. Despite uncertain performance in the last few months, the Stock's fundamental indicators remain somewhat strong which may send shares a bit higher in December 2024. The current disturbance may also be a sign of long term up-swing for the company investors.
Krebs Biochemicals and 

Risk-Adjusted Performance

7 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in Krebs Biochemicals and are ranked lower than 7 (%) of all global equities and portfolios over the last 90 days. Despite fairly weak fundamental drivers, Krebs Biochemicals demonstrated solid returns over the last few months and may actually be approaching a breakup point.

Generic Engineering and Krebs Biochemicals Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Generic Engineering and Krebs Biochemicals

The main advantage of trading using opposite Generic Engineering and Krebs Biochemicals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Generic Engineering position performs unexpectedly, Krebs Biochemicals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Krebs Biochemicals will offset losses from the drop in Krebs Biochemicals' long position.
The idea behind Generic Engineering Construction and Krebs Biochemicals and pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Volatility module to check portfolio volatility and analyze historical return density to properly model market risk.

Other Complementary Tools

Global Correlations
Find global opportunities by holding instruments from different markets
Economic Indicators
Top statistical indicators that provide insights into how an economy is performing
Content Syndication
Quickly integrate customizable finance content to your own investment portal
Price Transformation
Use Price Transformation models to analyze the depth of different equity instruments across global markets
Portfolio Center
All portfolio management and optimization tools to improve performance of your portfolios